resplex
assay
qiagen
design
amplifi
detect
dna
six
bacteri
respiratori
pathogen
assay
compar
realtim
pcr
assay
base
upon
target
sequenc
abil
detect
target
bacteria
use
stock
strain
specimen
respiratori
diseas
patient
resplex
assay
somewhat
less
sensit
realtim
pcr
assay
offer
advantag
multipl
assay
singl
reaction
differenti
diagnosi
bacteri
respiratori
diseas
pneumonia
public
health
prioriti
high
morbid
mortal
rate
year
estim
bacteri
pneumoniarel
hospit
death
occur
unit
state
acut
respiratori
infect
caus
wide
rang
microorgan
clinic
difficult
make
distinct
caus
infecti
agent
convent
diagnosi
usual
base
microbi
cultur
cultur
techniqu
timeconsum
pathogen
like
legionella
pneumophila
mycoplasma
pneumonia
chlamydia
pneumonia
difficult
cultur
also
streptococcu
pneumonia
cultur
upper
respiratori
tract
mani
children
adult
absenc
respiratori
diseas
addit
individu
pneumococc
infect
receiv
antibiot
neg
cultur
result
thu
varieti
diagnost
method
includ
antigen
test
pcr
appli
differ
clinic
specimen
urin
blood
bronchoalveolar
lavag
fluid
transthorac
needl
aspir
nasopharyng
np
oropharyng
swab
use
defin
invas
noninvas
respiratori
infect
fatal
case
formalinfix
paraffinembed
ffpe
tissu
often
specimen
avail
nucleic
acid
extract
specimen
limit
volum
therefor
number
assay
perform
variou
pathogen
limit
realtim
pcr
assay
gener
rapid
sensit
specif
multiplex
pcr
assay
could
use
rapid
simultan
detect
coinfect
respiratori
bacteria
specimen
without
addit
cost
process
howev
multiplex
pcr
still
challeng
amplif
condit
multipl
target
often
incompat
high
concentr
primer
typic
yield
elev
background
read
reduc
amplif
effici
targetenrich
multiplex
pcr
address
issu
via
applic
liquidphas
beadbas
array
luminex
xmap
technolog
multiplex
pcr
resplex
assay
qiagen
valencia
ca
develop
part
cooper
research
develop
agreement
center
diseas
control
prevent
cdc
genaco
biomed
product
inc
intend
clinic
diagnost
use
assay
amplifi
detect
genespecif
dna
sequenc
six
respiratori
bacteri
pathogen
pneumonia
lyta
neisseria
meningitidi
ctra
encapsul
nonencapsul
haemophilu
influenza
bexa
l
pneumophila
mip
mycoplasma
pneumonia
atpas
c
pneumonia
ompa
object
studi
design
resplex
assay
use
modif
cdc
realtim
pcr
primer
probe
c
pneumonia
l
pneumophila
pneumonia
n
meningitidi
pneumonia
examin
applic
assay
detect
bacteria
associ
respiratori
infect
analyt
specif
limit
detect
resplex
assay
determin
assay
compar
immunohistochemistri
ihc
realtim
pcr
abil
detect
specimen
np
swab
ffpe
tissu
follow
bacteri
isol
use
determin
analyt
sensit
resplex
assay
pneumonia
analyt
specif
resplex
assay
determin
use
panel
dna
microorgan
normal
found
respiratori
tract
speci
phylogenet
relat
organ
tabl
qiagen
qiaamp
dna
mini
kit
qiagen
valencia
ca
use
extract
nucleic
acid
bacteri
isol
dna
concentr
determin
use
nd
spectrophotomet
nano
drop
technolog
de
extract
store
comparison
limit
detect
resplex
assay
realtim
pcr
dna
templat
serial
dilut
equal
amount
dna
use
assay
twentysix
ffpe
sampl
fatal
case
pneumonia
meningitismeningococcemia
bacteri
etiolog
pneu
multipleag
infect
pneumonia
h
influenza
l
pneumophila
n
meningitidi
n
confirm
ihc
cultur
test
resplex
assay
organismspecif
realtim
pcr
assay
dna
extract
specimen
qiaamp
dna
mini
kit
qiagen
valencia
ca
follow
tissu
extract
protocol
fortynin
np
swab
sampl
obtain
patient
hospit
pneumonia
np
sampl
test
previous
use
realtim
pcr
assay
pneumonia
c
pneumonia
sampl
also
analyz
pneumonia
realtim
pcr
test
resplex
assay
clinic
sampl
extract
use
qiaamp
viru
biorobot
mdx
extractor
qiagen
valencia
ca
resplex
assay
protocol
follow
sampl
bacteri
dna
ngl
ad
mixtur
contain
l
hotstart
taq
master
mix
qiagen
inc
ca
l
resplex
superprim
l
steril
water
notempl
control
sampl
includ
ad
l
water
place
dna
sampl
volum
sampl
amplifi
thermocycl
follow
condit
initi
pcr
activ
min
enrich
cycl
min
min
cycl
twostep
cycl
min
cycl
threestep
cycl
cycl
final
extens
min
pcr
product
hybrid
probecoupl
bead
flatbottom
plate
use
luminex
xy
platform
heater
prewarm
resplex
bead
mix
resuspend
vortex
least
second
fortyf
microlit
hybrid
master
mix
prepar
mix
l
hybrid
buffer
l
resplex
bead
mix
dispens
well
five
microlit
pcr
product
ad
mix
thoroughli
sampl
hybrid
min
hybrid
l
streptavidinphycoerythrin
dilut
detect
buffer
ad
sampl
sampl
mix
briefli
incub
min
reaction
stop
ad
l
stop
buffer
prewarm
sampl
analyz
luminex
follow
manufactur
instruct
collect
data
export
excel
microsoft
corpor
redmond
wa
realtim
pcr
assay
sampl
serial
dilut
extract
dna
organ
ad
l
pcr
master
mixtur
consist
taqman
univers
pcr
master
mix
appli
biosystem
foster
citi
ca
nm
primer
nm
fluoresc
label
probe
depend
pcr
protocol
serial
dilut
contain
copi
dna
per
pcr
primer
probe
previous
titrat
check
amplif
effici
amplif
detec
march
guest
http
jcmasmorg
tion
perform
abi
prism
sequenc
detect
system
resplex
assay
detect
dna
sampl
strain
except
h
influenza
serotyp
isol
detect
probe
posit
bexa
probe
compar
analysi
limit
detect
multiplex
pcr
assay
realtim
pcr
assay
demonstr
resplex
assay
similar
sensit
n
meningitidi
less
sensit
detect
pneumonia
l
pneumophila
pneumonia
resplex
assay
less
sensit
detect
c
pneumonia
respect
realtim
pcr
assay
limit
detect
h
influenza
compar
realtim
pcr
assay
realtim
pcr
assay
target
bexa
avail
cdc
resplex
assay
react
dna
organ
repres
respiratori
pathogen
normal
respiratori
flora
tabl
compar
result
ihc
stain
realtim
pcr
resplex
assay
ffpe
specimen
shown
tabl
fairli
good
agreement
among
three
assay
although
resplex
assay
detect
slightli
fewer
agent
specimen
known
contain
nucleic
acid
multipl
pathogen
resplex
assay
perform
np
swab
specimen
known
posit
realtim
pcr
three
pathogen
c
pneumonia
pneumonia
pneumonia
tabl
resplex
assay
detect
c
pneumonia
pneumonia
pneumoniaeposit
sampl
respect
specimen
two
organ
detect
realtim
pcr
resplex
assay
detect
clear
need
multiplex
pcr
assay
especi
diagnosi
respiratori
diseas
realtim
pcr
assay
respiratori
pathogen
sensit
specif
finit
volum
clinic
specimen
limit
number
assay
may
perform
singl
patient
need
rapid
assay
highlight
event
sever
acut
respiratori
syndrom
outbreak
threat
pandem
influenza
varieti
strategi
advanc
combin
nucleic
acid
amplif
assay
mani
suffer
consequ
incompat
primer
set
nonspecif
reaction
resplex
assay
attempt
overcom
problem
use
nest
primer
target
along
super
primer
use
higher
concentr
later
pcr
amplicon
detect
util
luminex
platform
allow
recognit
multipl
target
singl
assay
resplex
assay
design
part
cooper
research
develop
agreement
cdc
crada
primer
probe
sequenc
inform
cdc
realtim
pcr
assay
pneumonia
c
pneumonia
l
pneumophila
n
meningitidi
pneumonia
studi
compar
realtim
pcr
assay
resplex
assay
use
number
stock
strain
establish
analyt
sensit
limit
detect
analyt
specif
addit
number
previous
test
clinic
specimen
simultan
test
assay
ihc
test
avail
tissu
specimen
import
sinc
defin
organ
caus
patholog
demonstr
organ
area
inflamm
contrast
organ
identifi
method
cultur
pcr
contamin
specimen
np
swab
clinic
signific
clearli
defin
resplex
assay
detect
dna
strain
bacteria
associ
respiratori
tract
suggest
high
analyt
specif
limit
detect
resplex
assay
somewhat
lower
pathogen
especi
c
pneumonia
assay
may
lack
sensit
detect
nt
h
influenza
strain
high
divers
gene
consid
nt
h
influenza
react
bexa
probe
design
detect
encapsul
h
influenza
addit
encapsul
h
influenza
strain
may
react
probe
resplex
assay
less
sensit
detect
respiratori
pathogen
np
swab
shown
tabl
detect
sampl
posit
c
pneumonia
posit
pneumonia
posit
pneumonia
studi
bias
favor
realtim
pcr
assay
sinc
mani
specimen
select
base
upon
fact
posit
assay
somewhat
lower
sensit
resplex
assay
may
compens
overal
effici
multiplex
assay
detect
multipl
pathogen
singl
specimen
resplex
assay
evalu
prospect
surveil
studi
respiratori
diseas
comparison
valid
assay
